Z.ai ARR Upgraded 25% to $3B After $5B Capital Injection — Enterprise AI Inflection
An ARR revision of this magnitude driven by a single capital event signals genuine monetization inflection. The $5B injection values Z.ai above most Western AI Series D comps and confirms China's domestic AI stack competes on enterprise revenue, not just benchmark positioning — a fundamental re-rating catalyst for the onshore AI cohort.